Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07213531 · ClinicalTrials.gov registry record
Enhanced Valves Interventions and Safe AI Generated End Results
A clinical trial of Heart Valve Disease and TAVI, sponsored by Montreal Heart Institute.
- Recruiting
- Registry status
- 21,000
- Enrollment target
- 15
- Study locations
NCT07213531 is a study of Heart Valve Disease and TAVI that is actively recruiting participants, run by Montreal Heart Institute. The registered enrollment target is 21,000 participants. The trial reports 15 study locations across 3 states.
The verdict
NCT07213531, a study of Heart Valve Disease and TAVI, is actively recruiting participants, sponsored by Montreal Heart Institute.
- RECRUITING
- Registry status
- 21,000 participants
- Enrollment target
- 15
- Study locations
Study Summary
This non-interventional study aims to use artificial intelligence to improve the prediction of transcatheter heart valve interventions and optimize patient outcomes. It is based on the analysis of retrospective data from various specialized centers worldwide.
Interventions
- DIAGNOSTIC_TEST Medical imaging analysis via artificial intelligence algorithms
Study Locations (15)
Other
- St Michael's Hospital Toronto - Toronto
- St Paul's Hospital Vancouver - Vancouver
- Centre Hospitalier Universitaire (CHU) de Bordeaux, 12 rue Dubernat 33404 Talence cedex - Bourdeaux
- CHU Lille - Lille
- CHU Marseille - Marseille
- Centre Cardiologique du Nord Paris - Paris
- Institut Cardiovasculaire Paris-Sud Paris - Paris
- Centre Hospitalier Universitaire Rennes - Rennes
- Clinque Pasteur Toulouse - France - Toulouse
- University Medical Center Hamburg-Eppendorf - Hamburg
- Heart Valve Center Mainz - Mainz
- Istituto Clinico Città di Brescia - Brescia
- San Raffaele Heart Valve Center Milan - Milan
New York
- Montefiore Medical Center New York - New York
Quebec
- Montreal Heart Institute, 5000 Rue Bélanger, Montréal - Montreal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21,000 participants |
| Start Date | 2024-05-01 |
| Est. Completion | 2029-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07213531
The ClinicalTrials.gov registry entry for NCT07213531 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 21,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montreal Heart Institute, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 8 conditions, with Heart Valve Disease appearing as the primary indexed condition, and to 1 intervention - of which Medical imaging analysis via artificial intelligence algorithms is the first listed.
NCT07213531 reports 15 study locations spanning 3 distinct geographic areas - top geographies include Other, New York, Quebec.
Frequently Asked Questions
What is clinical trial NCT07213531 about?
NCT07213531 is a clinical study titled "Enhanced Valves Interventions and Safe AI Generated End Results". This non-interventional study aims to use artificial intelligence to improve the prediction of transcatheter heart valve interventions and optimize patient outcomes. It is based on the analysis of retrospective data from various specialized centers worldwide.
What is the current status of trial NCT07213531?
This trial is currently recruiting. The enrollment target is 21,000 participants. The study started on 2024-05-01. Estimated completion is 2029-05.
What conditions does trial NCT07213531 study?
This clinical trial studies the following conditions: Heart Valve Disease, TAVI, M-TEER, TTVI, TMVI.
What interventions are being tested in trial NCT07213531?
The interventions under investigation include: Medical imaging analysis via artificial intelligence algorithms (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07213531?
This trial is sponsored by Montreal Heart Institute, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07213531 being conducted?
This trial has 15 study locations across New York, Quebec. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Valve Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.